Attached files
| file | filename |
|---|---|
| 10-K - ANNUAL REPORT - Tamir Biotechnology, Inc. | alfacell_10k-073109.htm |
| EX-23.1 - CONSENT OF J.H. COHN LLP - Tamir Biotechnology, Inc. | ex23-1.htm |
| EX-31.2 - CERTIFICATION - Tamir Biotechnology, Inc. | ex31-2.htm |
| EX-31.1 - CERTIFICATION - Tamir Biotechnology, Inc. | ex31-1.htm |
| EX-23.2 - CONSENT OF KPMG LLP - Tamir Biotechnology, Inc. | ex23-2.htm |
| EX-10.51 - TERMINATION AGREEMENT - Tamir Biotechnology, Inc. | ex10-51.htm |
| EX-10.52 - AMENDMENT TO RETIREMENT AGREEMENT - Tamir Biotechnology, Inc. | ex10-52.htm |
EXHIBIT
32.1
CERTIFICATION
PURSUANT TO
18
U.S.C. §1350,
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the annual report of Alfacell Corporation (the “Company”) on
Form 10-K for the fiscal year ended July 31, 2009 as filed with the Securities
and Exchange Commission on the date hereof (the “Report”), I, Charles Muniz,
Chief Executive Officer and Chief Financial Officer of the Company, certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:
|
|
1.
|
The
Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934;
and
|
|
|
2.
|
The
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.
|
November
13, 2009
|
/s/ CHARLES MUNIZ
Charles
Muniz
Chief
Executive Officer and Chief Financial Officer
(Principal
Executive Officer, Principal Financial Officer
and
Principal Accounting Officer of Alfacell
Corporation)
|
A signed original of this
written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has
been provided to Alfacell Corporation and will be furnished to the Securities
and Exchange Commission or its staff upon
request.